Hoth Therapeutics 和 Acurx Pharmaceuticals 各向比特幣分配 100 萬美元，反映出人們對加密貨幣作為金融資產的興趣日益濃厚

Hoth Therapeutics 是一家臨床階段的生物製藥公司，將向比特幣分配 100 萬美元，理由是比特幣具有對沖通膨和價值儲存的潛力。

Two publicly traded pharmaceutical companies, Hoth Therapeutics and Acurx Pharmaceuticals, have each announced plans to allocate up to $1 million to Bitcoin as part of their treasury strategies.

兩家上市製藥公司 Hoth Therapeutics 和 Acurx Pharmaceuticals 均宣布計劃向比特幣分配最多 100 萬美元，作為其財務策略的一部分。

Hoth Therapeutics, a clinical-stage biopharmaceutical company, will be adding Bitcoin to its treasury, specifically allocating $1 million. The move is part of a broader trend of Bitcoin adoption by businesses, with the company citing the cryptocurrency’s potential as a hedge against inflation and a store of value.

Hoth Therapeutics 是一家臨床階段的生物製藥公司，將在其資金庫中添加比特幣，具體分配 100 萬美元。此舉是企業採用比特幣的更廣泛趨勢的一部分，該公司指出加密貨幣具有對沖通膨和價值儲存的潛力。

The company’s board of directors approved the move, which is influenced by several factors including the approval of exchange-traded funds (ETFs) and increased market activity.

該公司董事會批准了這項舉措，這是受到交易所交易基金（ETF）批准和市場活動增加等多種因素影響的。

“The approval of bitcoin ETFs and the trust of major financial institutions in this asset class, combined with the observed strength of bitcoin as an inflation hedge and store of value over the last several months, have influenced our decision,” said Robb Knie, CEO of Hoth, in a statement.

執行長Robb Knie 表示：「比特幣ETF 的批准和主要金融機構對這一資產類別的信任，再加上過去幾個月觀察到的比特幣作為通膨對沖和保值手段的實力，影響了我們的決定。

Hoth’s treasury strategy is focused on preserving capital and generating a return on cash not needed for operations over the next 12 to 18 months. The company’s drug development plans will not be affected by this decision.

霍斯的財務策略著重於保存資本並產生未來 12 至 18 個月營運不必要的現金回報。公司的藥物開發計劃不會受到該決定的影響。

“We believe that bitcoin will serve as a strong treasury reserve asset,” said David P. Luci, CEO of Acurx, in a statement.

Acurx 執行長 David P. Luci 在一份聲明中表示：“我們相信比特幣將成為一種強大的國庫儲備資產。”

The company’s financial strategy is centered on deploying cash efficiently and includes a preference for inflation-resistant investments.

該公司的財務策略以有效配置現金為中心，並優先考慮抗通膨投資。

“We believe bitcoin to be an optimal treasury reserve asset. It is a scarce digital asset with a limited supply of 21 million bitcoin ever to be created, rendering it inherently inflation resistant,” Luci added.

「我們相信比特幣是最佳的國庫儲備資產。它是一種稀缺的數位資產，比特幣的發行量有限，為 2,100 萬枚，因此具有固有的抗通膨能力。